knowledge -WSS

knowledge

author：leisure time 2025-09-29 20:51:51 - browse：6679

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： 2 officers injured in shooting in Orlando, police say

WSS

Florida officials tell state schools to teach AP Psychology 'in its entirety'

FDA scientists endorse Pfizer/BioNTech Covid

The a glaring gap in research on serious mental illness and primary care

PhRMA sues HHS over Medicare drug price negotiation

Chris Christie meets with Zelenskyy during Ukraine trip

Pfizer's Covid pill remains 89% effective in final analysis, company says

knowledge

knowledge

The need-to-know this morning

Novavax’s money is going in the wrong direction

explore

How to save PrEP access — and even expand it

4th of July breaks record for highest global temperature ever measured

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Cancer drug shortages should be causing more outrage

Study links childhood stress with decline in older age

In age of alternative facts, a scholarly course on calling out crap

CDC recommends RSV monoclonal antibody for infants

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Listen: Biogen's messy board & Laronde's data problem

knowledge

These geoengineering technologies could help combat the climate crisis, scientists say

CDC recommends RSV monoclonal antibody for infants

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Bacterial infection may be ‘key event’ in endometriosis, study says

New case study details death in closely watched Alzhiemer's trial

entertainment

focus

leisure time

focus